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Introduction
• Acute ischemic strokes (AIS) are a prominent cause of death 1, 2, 3
• Proximity to primary stroke center
is vital 1, 3, 4
• Telemedical intervention can 
overcome this barrier 4, 5, 6, 7
AIS patient's presentation to the ED. Adapted from Kleindorfer, D., et al.
(2004).
Introduction
• Previous studies have shown adherence to accepted stroke treatment 
guidelines with telestroke 8, 9, 10, 11
• Few studies have:
– Used extensive patient cohorts 8, 9, 10, 11
– Longitudinally tracked patients 





– How does telestroke intervention affect the treatment and outcomes 
of patients who are not within proximity to a primary stroke center?
• Hypothesis
– Through telestroke intervention, patients will receive treatment more 
rapidly and therefore have reduced mortality rates and neurological 
sequelae as a result of AIS.
Methods
• Study is a retrospective chart review of a database for 
subjects who received telestroke consultation from 
2015-2019
• Cohort size of 9,694 patients 
• Independent Variable: Utilization of telestroke 
intervention
• Comparison Group: Standard of care




– Multivariable logistic regression to control for 
confounding variables
– Utilization of Student’s T-test to assess significance of 
data
• Findings
– Average onset to consult time: 227.13 minutes (within 4.5 hours)
– 195 (2.1%) patients experienced a major complication
– 155 (1.7%) patients expired despite treatment
Approach & Results














Arrived < 3 hrs Arrived < 2 hrs
Conclusions
• Confirmation that quicker access to 
consultation results in more positive 
outcomes
• Similar tPA usage rates to other studies 3, 4, 5
– Far exceed national average
• This study will push the field towards more 
widespread use of telemedicine
Future Directions
• Research
– Continued analysis of data pool
– Drafting of manuscript for publication
• Implementation
– Insight into use of telemedicine for other rapid 
onset conditions
– Survey caretakers or survivors about experience
Acknowledgements
• Thank you to Dr. Sweid, Daniel Moylan, 
Danial Joffe, and Michael Knapp. 
References
1. Madhavan, M. & Karceski, S. (2016). Telestroke: Is it safe and effective. 
Neurology, 87(13), e145-e148. https://doi.org/10.1212/WNL.000000000000 
3244
2. Legris, N., et al. (2016). Telemedicine for the acute management of stroke in 
Burgundy, France: an evaluation of effectiveness and safety. Eur. J. Neurol., 
23(9), 1433-1440. https://doi.org/10.1111/ene.13054
3. Chalouhi, N., et al. (2013). Intravenous tissue plasminogen activator 
administration in community hospitals facilitated by telestroke service. 
Neurosurgery, 23(9), 1433-1440. DOI: 10.1227/NEU.0000000000000073 
4. Akbik, F., et al. (2016). Telestroke-the promise and the challenge. Part two-
expansion and horizons. J. Neurointerv. Surg., 9, 361-365. 
http://dx.doi.org/ 10.1136/neurintsurg-2016-012340
5. Sanders, K.A., et al. (2016). Improving telestroke treatment times in an 
expanding network of hospitals. J. Stroke Cerebrovasc. Dis., 25(2), 288-291. 
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.09.030
6. Yaghi, S., Hinduja, A., & Bianchi, N. (2016). Predictors of major improvement 
after intravenous thrombolysis in acute ischemic stroke. Int. J. Neurosci, 
126(1), 67-69. https://doi.org/10.3109/00207454.2014.1002611
References
7. Akbik, F., et al. (2016). Telestroke-the promise and the challenge. Part 
one: growth and current practice. J. Neurointerv. Surg., 9, 357-360. 
http://dx.doi.org/10.1136/neurintsurg-2016-012340
8. Kleindorfer, D., et al. (2004). Eligibility for Recombinant Tissue 
Plasminogen Activator in Acute Ischemic Stroke. Stroke, 35(2), e27-
e29. https://doi.org/10.1161/01.STR.0000109767.11426.17
9. Fonarow, G. (2011). Timeliness of Tissue-Type Plasminogen Activator 
Therapy in Acute Ischemic Stroke. Circulation, 123(7), 750-758. 
https://doi.org/10.1161/CIRCULATIONAHA.110.974675
10. Badhiwala, J. (2015). Endovascular Thrombectomy for Acute Ischemic 
Stroke: A Meta-analysis. JAMA, 314(17). 1832-1843. doi:10.1001/ 
jama.2015.13767
11. Sweid, A., et al. (2019). Correlation between pre-admission blood 
pressure and outcome in a large telestroke cohort. J. Clin. 
Neurosci., 62, 33-37. https://doi.org/10.1016/j.jocn.2019.01.014
